home / stock / rtsl / rtsl news


RTSL News and Press, Rapid Therapeutic Science Laboratories Inc From 10/07/21

Stock Information

Company Name: Rapid Therapeutic Science Laboratories Inc
Stock Symbol: RTSL
Market: OTC
Website: rtslco.com

Menu

RTSL RTSL Quote RTSL Short RTSL News RTSL Articles RTSL Message Board
Get RTSL Alerts

News, Short Squeeze, Breakout and More Instantly...

RTSL - Rapid Therapeutic Science Laboratories Postpones Shareholder Update Conference Call

DALLAS, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that its shareholder update c...

RTSL - Rapid Therapeutic Science Laboratories to Present at the LD Micro Main Event Conference

DALLAS, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that CEO Donal Schmidt will p...

RTSL - Rapid Therapeutic Science Laboratories to Conduct a Shareholder Update Conference Call on Thursday, October 7, 2021

DALLAS, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces that CEO Donal Schmidt will conduct...

RTSL - Rapid Therapeutic Announces Private Placement of $1.9 Million Convertible Notes

DALLAS, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) (“RTSL” or the “Company”), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds,...

RTSL - Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits

Palm Beach, FL – June 10, 2021 – Cannabidiol (CBD) extract is a product that’s derived from cannabis. It’s a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana plants, CBD doesn’t create a ...

RTSL - Rapid Therapeutic Finalizes Lab Work on Pharmaceutical Formulas

DALLAS, June 10, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today that it has concluded lab development...

RTSL - Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

Palm Beach, FL – June 8, 2021 – The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing Cannabidiol markets. The global COVID-19 pandemic outbreak has had an unprec...

RTSL - Rapid Therapeutic Prepares to bring Sublingual Spray Products to Market

DALLAS, June 08, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today it is preparing to launch a marketing...

RTSL - Global Cannabidiol (CBD) Market Size Expected to Reach $55 Billion In 2028

Palm Beach, FL – June 2, 2021 – Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes pr...

RTSL - Rapid Therapeutic Prepares to file Investigational New Drug Application for its CBD Metered Dose Inhaler with FDA

DALLAS, June 02, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today it has executed two (2) contracts to c...

Previous 10 Next 10